Intravitreal aflibercept superior to eye laser for diabetic retinopathy at 1 year
Intravitreal injection of the anti-VEGF* agent aflibercept shows superior visual acuity outcomes over panretinal laser photocoagulation (PRP) at 1 year in eyes with active proliferative diabetic retinopathy (PDR) without diabetic macular oedema, according to the CLARITY** study.
Best Website Host:
www.bluehost.comLinkback:
https://tubagbohol.mikeligalig.com/index.php?topic=121615.0